AHR and early-onset autosomal dominant Alzheimer disease: Most recently patients with Alzheimer’s disease have been reported to have increased circulating levels of I.S. and disruption of AhR signaling [33], giving further evidence for the role of I.S. in contributing to cognitive dysfunction.